AI assistant
Sending…
BeOne Medicines Ltd. — Director's Dealing 2018
Apr 4, 2018
30073_dirs_2018-04-04_745e7ef5-a0f1-4ac1-8b6c-536bc2dcf971.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2018-04-02
Reporting Person: su Jingshyh S (Director)
More from BeOne Medicines Ltd.
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Apr 14
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 6